Literature DB >> 2118540

Placental and pituitary growth hormone secretion during pregnancy in acromegalic women.

A Beckers1, A Stevenaert, J M Foidart, G Hennen, F Frankenne.   

Abstract

It is now well established that during the second half of normal pregnancy, the human placenta secretes its specific GH variant (placental GH) in increasing amounts up to delivery. During the same period, pituitary GH secretion is progressively suppressed. The present study was aimed at clarifying the physiology of GH secretion in pregnant acromegalic women. Two young women remained acromegalic despite transphenoidal removal of their pituitary adenoma. Increased basal levels of GH and insulin-like growth factor-I (IGF-I) as well as paradoxical GH release after TRH injection were noted. Both women became pregnant and delivered term babies without any complication. In both patients, pituitary GH remained elevated during the entire pregnancy, contrary to the situation in normal women. Paradoxical GH release after TRH treatment was also present, whereas no response was observed in five normal control subjects. GH pulsatility studies revealed a highly pulsatile secretory pattern of pituitary GH, in contrast to that in normal woman, whose placental GH is secreted tonically. Tissue placental GH concentrations were within the range of levels in normal placentas. An increase in serum IGF-I in late pregnancy was also similar to that observed in normal pregnancy. These findings confirm that increased IGF-I levels are not pituitary GH dependent in late pregnancy. They add new evidence that adenomatous somatotrophs lack an IGF-I-dependent feedback regulation present in normal somatotrophs.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2118540     DOI: 10.1210/jcem-71-3-725

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  13 in total

1.  Clinical and biochemical improvement in acromegaly during pregnancy.

Authors:  S L Lau; S McGrath; D Evain-Brion; R Smith
Journal:  J Endocrinol Invest       Date:  2008-03       Impact factor: 4.256

2.  Tamoxifen enhances the control of acromegaly treated with somatostatin analog lanreotide.

Authors:  Jean-Christophe Maiza; Stéphane Castillo-Ros; Maria Matta; Antoine Bennet; Philippe Caron
Journal:  Pituitary       Date:  2012-12       Impact factor: 4.107

Review 3.  Placental growth hormones.

Authors:  Marie-Christine Lacroix; Jean Guibourdenche; Jean-Louis Frendo; Guillaume Pidoux; Danièle Evain-Brion
Journal:  Endocrine       Date:  2002-10       Impact factor: 3.633

Review 4.  Management of pituitary tumors in pregnancy.

Authors:  Marcello D Bronstein; Diane B Paraiba; Raquel S Jallad
Journal:  Nat Rev Endocrinol       Date:  2011-03-15       Impact factor: 43.330

Review 5.  Review of Presentation, Diagnosis and Management of Pituitary Tumours in Pregnancy.

Authors:  Kimberley Lambert; Catherine Williamson
Journal:  Obstet Med       Date:  2013-03-01

6.  Acromegaly in pregnancy.

Authors:  T George Koshy; Simon Rajaratnam; Jiji Elizabeth Mathews; Vedantam Rajshekhar
Journal:  Indian J Endocrinol Metab       Date:  2012-11

7.  Enhanced basal and disorderly growth hormone secretion distinguish acromegalic from normal pulsatile growth hormone release.

Authors:  M L Hartman; S M Pincus; M L Johnson; D H Matthews; L M Faunt; M L Vance; M O Thorner; J D Veldhuis
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

8.  Decreased IGF-1 concentration during the first trimester of pregnancy in women with normal somatotroph function.

Authors:  Marie-Laure Persechini; Isabelle Gennero; Solange Grunenwald; Delphine Vezzosi; Antoine Bennet; Philippe Caron
Journal:  Pituitary       Date:  2015-08       Impact factor: 4.107

Review 9.  Pituitary tumors and pregnancy: the interplay between a pathologic condition and a physiologic status.

Authors:  Rosario Pivonello; Maria Cristina De Martino; Renata S Auriemma; Carlo Alviggi; Ludovica F S Grasso; Alessia Cozzolino; Monica De Leo; Giuseppe De Placido; Annamaria Colao; Gaetano Lombardi
Journal:  J Endocrinol Invest       Date:  2014-01-16       Impact factor: 4.256

10.  General health status and intelligence scores of children of mothers with acromegaly do not differ from those of healthy mothers.

Authors:  Ozlem Haliloglu; Burak Dogangun; Bahar Ozcabi; Hanife Ugur Kural; Fatma Ela Keskin; Hande Mefkure Ozkaya; Fatma Colkesen Pamukcu; Elif Bektas; Burc Cagri Poyraz; Hakan Buber; Olcay Evliyaoglu; Pinar Kadioglu
Journal:  Pituitary       Date:  2016-08       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.